NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 52 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $30,000 | +233.3% | 56,537 | +334.9% | 0.00% | – |
| Q2 2020 | $9,000 | -87.0% | 13,000 | -89.1% | 0.00% | – |
| Q1 2020 | $69,000 | -78.9% | 119,181 | -11.0% | 0.00% | – |
| Q1 2019 | $327,000 | +890.9% | 133,897 | +493.0% | 0.00% | – |
| Q4 2018 | $33,000 | -82.6% | 22,578 | -67.9% | 0.00% | – |
| Q3 2018 | $190,000 | -39.1% | 70,444 | -21.3% | 0.00% | – |
| Q2 2018 | $312,000 | -18.1% | 89,536 | +18.1% | 0.00% | – |
| Q1 2018 | $381,000 | -40.2% | 75,808 | -28.8% | 0.00% | – |
| Q4 2017 | $637,000 | – | 106,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 191,028 | $462,000 | 0.08% |
| Sterling Investment Advisors, Ltd. | 5,000 | $12,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |